Knopp R H, Brandt K, Arky R A
J Toxicol Environ Health. 1976 Nov;2(2):417-28. doi: 10.1080/15287397609529443.
Given the potential use of a low-calorie sweetener during weight reduction, a toxicity study of chronic aspartame ingestion was conducted. Particular attention was given to possible long-term effects of aspartame on the fuel hormonal alterations characteristically caused by weight reduction. As a group mean age was 19.3 yr, body weight was 164.6 lb, and mean height was 65.4 in. Subjects were an average of 33% in excess of ideal body weight. The aspartame dose was 2.7 g/day and was compared on a double-blind randomized basis with a lactose placebo. Both materials were given in gelatin capsules. An average of 6.9 +/- 1.5 lb was lost by the aspartame group during the 13-wk study on a calculated 1,000-calorie diet. The placebo group lost 4.5 +/- 1.2 lb (no significant difference between the two groups). After an overnight fast, reductions in glucose and immunoreactive insulin were seen in both groups, while rising trends in immunoreactive glucagon were observed. These changes are all characteristic of calorie restriction. In no instance was there a detectable effect of the ingested aspartame. No meaningful effect of weight reduction or aspartame was seen on plasma triglyceride and cholesterol, nor on any other parameter of hematologic, hepatic, or renal function that was measured. Similarly, side effects were equally distributed between asparatame and placebo.
鉴于低热量甜味剂在减肥期间的潜在用途,开展了一项关于长期摄入阿斯巴甜的毒性研究。特别关注了阿斯巴甜对减肥典型引起的燃料激素变化可能产生的长期影响。研究组平均年龄为19.3岁,体重为164.6磅,平均身高为65.4英寸。受试者平均比理想体重超出33%。阿斯巴甜剂量为每日2.7克,并在双盲随机基础上与乳糖安慰剂进行比较。两种物质均装在明胶胶囊中给药。在为期13周、计算热量为1000卡路里的饮食研究期间,阿斯巴甜组平均减重6.9±1.5磅。安慰剂组减重4.5±1.2磅(两组间无显著差异)。禁食一夜后,两组均出现葡萄糖和免疫反应性胰岛素降低,同时观察到免疫反应性胰高血糖素呈上升趋势。这些变化都是热量限制的特征。在任何情况下,摄入的阿斯巴甜均未产生可检测到的影响。减肥或阿斯巴甜对血浆甘油三酯和胆固醇,以及所测量的任何其他血液学、肝脏或肾脏功能参数均未产生有意义的影响。同样,副作用在阿斯巴甜组和安慰剂组中分布相同。